Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4507

Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization Therapy Defibrillator (CRT-D)] and Geography (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2014-2022

LI_172091
Pages: 150
Mar 2017 | 1623 Views
face gplus_n
Author's : Garima Chandra
Tables: 42
Charts: 58
twit_n pr_n

Implantable Defibrillators Market Overview:

Implantable Defibrillators Market was valued at $6,006 million in 2015 and is expected to garner $8,449 million by 2022, registering a CAGR of 4.9% during the forecast period 2016 - 2022. The demand for implantable defibrillators is expected to increase globally during the forecast period due to rapid increase in geriatric population and rise in incidence of sudden cardiac arrest (SCA). However, factors such as lack of awareness towards the advantage of using implantable defibrillators, high cost of implantable defibrillators, and unfavorable reimbursement policies are anticipated to hamper the market growth. Rise in demand for ICDs for patients with nonischemic cardiomyopathy reduces the risk of mortality to about 23%, which is expected to offer new opportunities for the market players.

The implantable defibrillators market is segmented based on product type and geography. On the basis of product type, the market is categorized into transvenous implantable cardioverter-defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillators (S-ICDS), and cardiac resynchronization therapy defibrillator (CRT-D). Geographically, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Argentina, Egypt, Israel, South Africa, and rest of LAMEA).

Drivers, restraints, and opportunities

The impact of the driving factors is expected to surpass that of the restraints. Moreover, emergence of new technologies and increase in adoption of S-ICDs are anticipated to provide new growth opportunities in the near future.

North America held the largest market share in 2015, followed by Europe. However, Asia-Pacific is anticipated to register the highest CAGR owing to the large pool of patient population; increase in prevalence of cardiac disorders, arrhythmias, and sudden cardiac arrest; rise in demand for long-lasting battery life for ICD devices; improvement in healthcare infrastructure; and growth in geriatric population.

The key players operating in the global implantable defibrillators market include Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., St. Jude Medical, Inc., Biotronik Se & Co.KG, and Sorin Group.

Key Benefits:

  • This report provides an extensive analysis of the current & emerging market trends and dynamics in the global implantable defibrillators market.

  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

  • This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.

  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.

  • Region- and country-wise market conditions are analyzed in the report.

Implantable Defibrillators Market Key Segments:

By Product Type

  • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)

  • Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)

  • Cardiac Resynchronization Therapy Defibrillator (CRT-D)

By Geography

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • Australia

    • India

    • Rest of Asia-Pacific

  • LAMEA

    • Brazil

    • Argentina

    • Egypt

    • Israel

    • South Africa

    • Rest of LAMEA

 

Chapter: 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Market share analysis, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rising incidence of sudden cardiac arrest (SCA)
3.3.1.2. Technologically advanced implantable defibrillators
3.3.1.3. Presence of high unmet medical needs

3.3.2. Restraints

3.3.2.1. Limited insurance coverage
3.3.2.2. Presence of alternative modes of treatment

3.3.3. Opportunities

3.3.3.1. Lucrative opportunities in emerging economies

Chapter: 4 IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICDS)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (T-ICDS)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast, by country
5.2.4. Market size and forecast, by product

5.2.4.1. U.S. market size and forecast
5.2.4.2. Canada market size and forecast
5.2.4.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast, by country
5.3.4. Market size and forecast, by product

5.3.4.1. UK market size and forecast
5.3.4.2. Germany market size and forecast
5.3.4.3. France market size and forecast
5.3.4.4. Italy market size and forecast
5.3.4.5. Spain market size and forecast
5.3.4.6. Rest of Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast, by country
5.4.4. Market size and forecast, by product

5.4.4.1. Japan market size and forecast
5.4.4.2. India market size and forecast
5.4.4.3. China market size and forecast
5.4.4.4. Australia market size and forecast
5.4.4.5. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast, by country
5.5.4. Market size and forecast, by product

5.5.4.1. Brazil market size and forecast
5.5.4.2. Argentina market size and forecast
5.5.4.3. Egypt market size and forecast
5.5.4.4. Israel market size and forecast
5.5.4.5. South Africa market size and forecast
5.5.4.6. Rest of LAMEA market size and forecast

Chapter: 6 COMPANY PROFILES

6.1. BOSTON SCIENTIFIC CORPORATION

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. LIVANOVA PLC COMPANY

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. IMRICOR MEDICAL SYSTEMS

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments

6.4. MICROPORT SCIENTIFIC CORPORATION

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. MAYO CLINIC US

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. MEDTRONIC PLC

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. MRI INTERVENTIONS, INC.

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. ST. JUDE MEDICAL, INC.

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

6.9. BIOTRONIK SE & CO.KG

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments

6.10. SORIN GROUP

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE,  2014-2022 ($MILLION)
TABLE 2. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE,  2014-2022 (THOUSAND UNIT)
TABLE 3. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICDS) MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 4. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICDS) MARKET, BY REGION, 2014-2022 (THOUSAND UNIT)
TABLE 5. TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (T-ICDS) MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 6. TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (T-ICDS) MARKET, BY REGION, 2014-2022 (THOUSAND UNIT)
TABLE 7. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 8. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MARKET, BY REGION, 2014-2022 (THOUSAND UNIT)
TABLE 9. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 10. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION, 2014-2022 (THOUSAND UNIT)
TABLE 11. NORTH AMERICA IMPLANTABLE DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 12. NORTH AMERICA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 13. NORTH AMERICA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 (THOUSAND UNIT)
TABLE 14. EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 15. EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 16. EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 (THOUSAND UNIT)
TABLE 17. ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, BY COUNTRY,  2014-2022 ($MILLION)
TABLE 18. ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 19. ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 (THOUSAND UNIT)
TABLE 20. LAMEA IMPLANTABLE DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 21. LAMEA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 22. LAMEA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 (THOUSAND UNIT)
TABLE 23. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 24. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 25. LIVANOVA: COMPANY SNAPSHOT
TABLE 26. LIVANOVA: OPERATING SEGMENTS
TABLE 27. IMRICOR: COMPANY SNAPSHOT
TABLE 28. IMRICOR: OPERATING SEGMENTS
TABLE 29. MICROPORT: COMPANY SNAPSHOT
TABLE 30. MICROPORT: OPERATING SEGMENTS
TABLE 31. MAYO CLINIC: COMPANY SNAPSHOT
TABLE 32. MAYO CLINIC: OPERATING SEGMENTS
TABLE 33. MEDTRONIC: COMPANY SNAPSHOT
TABLE 34. MEDTRONIC: OPERATING SEGMENTS
TABLE 35. MRI INTERVENTIONS: COMPANY SNAPSHOT
TABLE 36. MRI INTERVENTIONS: OPERATING SEGMENTS
TABLE 37. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 38. ST. JUDE MEDICAL: OPERATING SEGMENTS
TABLE 39. BIOTRONIK: COMPANY SNAPSHOT
TABLE 40. BIOTRONIK: OPERATING SEGMENTS
TABLE 41. SORIN GROUP: COMPANY SNAPSHOT
TABLE 42. SORIN GROUP: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE,  2015 VS 2022 ($MILLION)
FIGURE 2. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET SEGMENTATION
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: BY NATURE, & TYPE OF DEVELOPMENT,  2014-2016
FIGURE 6. TOP INVESTMENT POCKETS
FIGURE 7. MARKET SHARE ANALYSIS, 2016
FIGURE 8. GLOBAL IMPLANTABLE DEFIBRILLATOR MARKET SNAPSHOT
FIGURE 9. U.S. IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 10. CANADA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 11. MEXICO IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 12. UK IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 13. GERMANY IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 14. FRANCE IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 15. ITALY IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 16. SPAIN IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 17. REST OF EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 18. JAPAN IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 19. INDIA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 20. CHINA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 21. AUSTRALIA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 22. REST OF ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 23. BRAZIL IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 24. ARGENTINA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 25. EGYPT IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 26. ISRAEL IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 27. SOUTH AFRICA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 28. REST OF LAMEA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 29. BOSTON SCIENTIFIC: REVENUE, 2014-2016 ($MILLION)
FIGURE 30. BOSTON SCIENTIFIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 31. BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 32. LIVANOVA: REVENUE, 2014-2016 ($MILLION)
FIGURE 33. LIVANOVA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 34. LIVANOVA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 35. IMRICOR: REVENUE, 2014-2016 ($MILLION)
FIGURE 36. IMRICOR: REVENUE BY SEGMENT, 2016 (%)
FIGURE 37. IMRICOR: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 38. MICROPORT: REVENUE, 2014-2016 ($MILLION)
FIGURE 39. MICROPORT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 40. MICROPORT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 41. MAYO CLINIC: REVENUE, 2014-2016 ($MILLION)
FIGURE 42. MAYO CLINIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 43. MAYO CLINIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 44. MEDTRONIC: REVENUE, 2014-2016 ($MILLION)
FIGURE 45. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 46. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 47. MRI INTERVENTIONS: REVENUE, 2014-2016 ($MILLION)
FIGURE 48. MRI INTERVENTIONS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 49. MRI INTERVENTIONS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 50. ST. JUDE MEDICAL: REVENUE, 2014-2016 ($MILLION)
FIGURE 51. ST. JUDE MEDICAL: REVENUE BY SEGMENT, 2016 (%)
FIGURE 52. ST. JUDE MEDICAL: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 53. BIOTRONIK: REVENUE, 2014-2016 ($MILLION)
FIGURE 54. BIOTRONIK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 55. BIOTRONIK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 56. SORIN GROUP: REVENUE, 2014-2016 ($MILLION)
FIGURE 57. SORIN GROUP: REVENUE BY SEGMENT, 2016 (%)
FIGURE 58. SORIN GROUP: REVENUE BY GEOGRAPHY, 2016 (%)

 

The implantable defibrillators market has witnessed rapid growth in the recent years, owing to the factors such as rise in incidence of chronic heart diseases and increase in awareness about the development of implantable defibrillators that prevents sudden cardiac arrest (SCA) in patients sustained with ventricular tachycardia or atrial fibrillation. The implantable defibrillators market has drawn the interest of healthcare professionals, as they allow them to monitor and treat sudden cardiac arrest (SCA) by analyzing patient heart rhythm and deliver shock required to restore its functioning. Therefore, ICDs constantly monitor the heart rhythm through electrodes and deliver treatments when abnormal heart rhythm is diagnosed.

The treatments through ICDs include pacing, cardioversion, and defibrillation to restore normal heart rhythm. Furthermore, increase in geriatric population and rise in use of devices to manage congestive heart failure are expected to drive the growth of the market. Advanced technology such as longer battery life, quadipolar leads, reduced inappropriate shocks, and less invasive installation of implantable defibrillators have propelled the demand to greater extent. However, lack of awareness about these devices in the developing economies is expected to restrain the market growth.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Implantable Defibrillators Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $4507
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $5007
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5907
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $7095
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9894
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts